Concord Biotech IPO vs Utkarsh Small Finance Bank IPO

Comparision between Concord Biotech IPO and Utkarsh Small Finance Bank IPO.

IPO Details

Concord Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Utkarsh Small Finance Bank IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Concord Biotech IPO	Utkarsh Small Finance Bank IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Kotak Mahindra Capital Company Limited Citigroup Global Markets India Private Limited Jefferies India Private Limited	ICICI Securities Limited Kotak Mahindra Capital Company Limited
Registrar	Link Intime India Private Ltd	Kfin Technologies Limited
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Concord Biotech IPO is up to ₹1,551.00 Cr whereas the issue size of the Utkarsh Small Finance Bank IPO is up to ₹500.00 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of Utkarsh Small Finance Bank IPO is ₹25.00 per share.

	Concord Biotech IPO	Utkarsh Small Finance Bank IPO
Face Value	₹1 per share	₹10 per share
Issue Price (Lower)	₹705.00 per share	₹23.00 per share
Issue Price (Upper)	₹741.00 per share	₹25.00 per share
Issue Price (Final)	₹741.00 per share	₹25.00 per share
Discount (Retail)
Discount (Employee)	₹70.00 per share
Market Lot Size	20 shares	600 shares
Fresh Issue Size		20,00,00,000 shares
Fresh Issue Size (Amount)		up to ₹500.00 Cr
OFS Issue Size	2,09,25,652 shares
OFS Issue Size (Amount)	up to ₹1,551.00 Cr
Issue Size Total	2,09,25,652 shares	20,00,00,000 shares
Issue Size Total (Amount)	up to ₹1,551.00 Cr	up to ₹500.00 Cr

IPO Timetable

Concord Biotech IPO opens on Aug 04, 2023, while Utkarsh Small Finance Bank IPO opens on Jul 12, 2023. The closing date of Concord Biotech IPO and Utkarsh Small Finance Bank IPO is Aug 08, 2023, and Jul 14, 2023, respectively.

	Concord Biotech IPO	Utkarsh Small Finance Bank IPO
Anchor Bid Date	Aug 03, 2023	Jul 11, 2023
Issue Open	Aug 04, 2023	Jul 12, 2023
Issue Close	Aug 08, 2023	Jul 14, 2023
Basis Of Allotment (Tentative)	Aug 11, 2023	Jul 19, 2023
Initiation of Refunds (Tentative)	Aug 14, 2023	Jul 20, 2023
Credit of Share (Tentative)	Aug 17, 2023	Jul 21, 2023
Listing date (Tentative)	Aug 18, 2023	Jul 21, 2023
Anchor Lockin End date 1	Sep 10, 2023	Aug 18, 2023
Anchor Lockin End date 2	Nov 09, 2023	Oct 17, 2023

Financials

Concord Biotech IPO P/E ratio is 32.29, as compared to Utkarsh Small Finance Bank IPO P/E ratio of 6.78.

Concord Biotech IPO

Utkarsh Small Finance Bank IPO

Financial

Concord Biotech IPO Financial Information (Restated Consolidated)
Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	1,182.55	1,312.80	1,513.98
Revenue	630.75	736.35	888.48
Profit After Tax	234.89	174.93	240.08
Net Worth	999.37	1,103.22	1,290.00
Reserves and Surplus
Total Borrowing	86.35	60.59	31.24

Amount in ₹ Crore

Utkarsh Small Finance Bank IPO Financial Information (Restated)
Period Ended	31 Mar 2020	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	9,404.32	12,137.91	15,063.77	19,117.54
Revenue	1,406.18	1,705.84	2,033.65	2,804.29
Profit After Tax	186.74	111.82	61.46	404.50
Net Worth	1,019.50	1,368.35	1,572.30	2,000.32
Reserves and Surplus	260.23	520.02	676.78	1,104.42
Total Borrowing	2,675.04	2,607.83	2,571.94	2,349.48

Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

44.08%

84.75%

Promoter Shareholding (Post-Issue)

44.08%

69.28%

P/E Ratio

32.29

6.78

Market Cap

₹7752.06 Cr.

₹2739.76 Cr.

ROE

20.06%%

22.64%%

ROCE

24.27%%

Debt/Equity

8.03

EPS

₹20.79

₹4.52

RoNW

20%%

20.22%%

Shares Offered

In the Concord Biotech IPO retail investors (RII) are offered 73,20,479 shares while in Utkarsh Small Finance Bank IPO retail investors are offered 73,20,479 shares. Qualified institutional buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 5,94,00,000 shares in Utkarsh Small Finance Bank IPO.

	Concord Biotech IPO	Utkarsh Small Finance Bank IPO
Anchor Investor Reserveration	62,74,695 shares	8,91,00,000 shares
Market Maker Reserveration
QIB	41,83,130 shares	5,94,00,000 shares
NII	31,37,348 shares	2,97,00,000 shares
RII	73,20,479 shares	1,98,00,000 shares
Employee	10,000 shares	20,00,000 shares
Others
Total	1,46,50,957 shares	11,09,00,000 shares

Bids Received (Subscription)

Concord Biotech IPO subscribed 24.87x in total, whereas Utkarsh Small Finance Bank IPO subscribed 110.77x.

	Concord Biotech IPO	Utkarsh Small Finance Bank IPO
QIB (times)	67.67x	135.71x
NII (times)	16.99x	88.74x
Big NII (times)	19.30x	91.83x
Small NII (times)	12.37x	82.57x
RII (times)	3.78x	78.38x
Employee (times)	24.48x	18.02x
Other (times)
Total (times)	24.87x	110.77x

Compare with others

Concord Biotech IPO	Utkarsh Small Finance Bank IPO
Aeroflex Industries IPO	TVS Supply Chain Solutions IPO
Pyramid Technoplast IPO	Concord Biotech IPO
India Shelter Finance IPO	SBFC Finance IPO
Balaji Speciality Chemicals IPO	Yatharth Hospital IPO
TVS Supply Chain Solutions IPO	Netweb Technologies India IPO
SBFC Finance IPO	Senco Gold IPO
Yatharth Hospital IPO	Cyient DLM IPO
Netweb Technologies India IPO	ideaForge Technology IPO
Utkarsh Small Finance Bank IPO	HMA Agro Industries IPO
Senco Gold IPO	IKIO Lighting IPO

Comments

Add a public comment...